Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 2
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
(-)-Epicatechin Is a Biased Ligand of Apelin Receptor.
Portilla-Martínez A, Ortiz-Flores MÁ, Meaney E, Villarreal F, Nájera N, Ceballos G. Portilla-Martínez A, et al. Among authors: ortiz flores ma. Int J Mol Sci. 2022 Aug 11;23(16):8962. doi: 10.3390/ijms23168962. Int J Mol Sci. 2022. PMID: 36012227 Free PMC article.
PXR is a target of (-)-epicatechin in skeletal muscle.
Ortiz-Flores M, Portilla-Martínez A, Cabrera-Pérez F, Nájera N, Meaney E, Villarreal F, Pérez-Durán J, Ceballos G. Ortiz-Flores M, et al. Heliyon. 2020 Oct 30;6(10):e05357. doi: 10.1016/j.heliyon.2020.e05357. eCollection 2020 Oct. Heliyon. 2020. PMID: 33163657 Free PMC article.
Arginase inhibition by (-)-Epicatechin reverses endothelial cell aging.
Garate-Carrillo A, Navarrete-Yañez V, Ortiz-Vilchis P, Guevara G, Castillo C, Mendoza-Lorenzo P, Ceballos G, Ortiz-Flores M, Najera N, Bustamante-Pozo MM, Rubio-Gayosso I, Villarreal F, Ramirez-Sanchez I. Garate-Carrillo A, et al. Among authors: ortiz flores m. Eur J Pharmacol. 2020 Oct 15;885:173442. doi: 10.1016/j.ejphar.2020.173442. Epub 2020 Aug 11. Eur J Pharmacol. 2020. PMID: 32795514 Free PMC article.
Improving Cardiovascular Risk in Postmenopausal Women with an (-)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial.
Nájera N, Ortíz-Flores M, Pérez-Durán J, Reyes-Muñoz E, Romo-Yañez J, Ortiz-Luna G, Villarreal F, Meaney E, Ceballos G, Montoya-Estrada A. Nájera N, et al. Among authors: ortiz flores m. J Clin Med. 2023 Dec 29;13(1):195. doi: 10.3390/jcm13010195. J Clin Med. 2023. PMID: 38202201 Free PMC article.
The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion.
Ortiz-Vilchis P, Ortiz-Flores M, Pacheco M, Ramirez-Sanchez I, Moreno-Ulloa A, Vega L, Ortiz A, Villarreal F, Rubio-Gayosso I, Najera N, Meaney E, Ceballos G. Ortiz-Vilchis P, et al. Among authors: ortiz flores m. Eur J Pharmacol. 2018 Jan 5;818:335-342. doi: 10.1016/j.ejphar.2017.11.007. Epub 2017 Nov 7. Eur J Pharmacol. 2018. PMID: 29126791
Overweight, Obesity, and Age Are the Main Determinants of Cardiovascular Risk Aggregation in the Current Mexican Population: The FRIMEX III Study.
Meaney E, Pérez-Robles E, Ortiz-Flores M, Perez-Ishiwara G, Meaney A, Munguía L, Roman G; Coalición por el Corazón de México; Nájera N, Ceballos G. Meaney E, et al. Among authors: ortiz flores m. J Clin Med. 2024 Apr 12;13(8):2248. doi: 10.3390/jcm13082248. J Clin Med. 2024. PMID: 38673521 Free PMC article.
11 results